In 2003, two randomized controlled trials showed that taking aspirin daily for as little as three years reduces…
In 2003, public health officials reported the re-emergence of H5N1 avian influenza for the first time since an…
In 2003, the Arizona Bioindustry Cluster was reincorporated and changed its name to the Arizona BioIndustry Association (ABA)….
In 2003, The Institute for Collaborative Biotechnologies (ICB) was founded as an Army-sponsored University Affiliated Research Center (UARC)….
In 2003, the Roskamp Institute, located in Sarasota, was founded by Robert Roskamp a philanthropist and Sarasota-based developer…
In 2003, The Broad Institute was announced with a $100 million gift from Eli and Edythe Broad. Discussions…
In 2003, the Institute for Research in Immunology and Cancer (IRIC) was created at the University of Montreal…
In 2003, the Medical University of South Carolina and Clemson University established a joint Bioengineering Program. Located on…
In 2003, Dr. William Hagopian at the Pacific Northwest Research Institute began Phase I of the hOKT3 study….
On Dec. 13, 2002, President Bush announced a major smallpox vaccination program to protect the nation against the…
On Dec. 12, 2002, the National Cancer Institute (NCI) announced that a clinical trial had shown that reducing…
On Dec. 5, 2002, the international Mouse Genome Sequencing Consortium announced the publication of a high-quality draft sequence…
On Dec. 3, 2002, Genentech drug Pegasys (peginterferon alfa-2a) was approved by the Food and Drug Administration (FDA)…
On Dec. 1, 202, Sidney Kimmel, founder and chairman of Jones Apparel Group, donated $150 million for cancer…
On Nov. 12, 2002, Cialis, a medication to treat male erectile dysfunction, manufactured by Eli Lilly and Company,…
On Oct. 29, 2002, an international research consortium launched a $100 million public-private effort to create the next…
On Oct. 16, 2002, patterns of proteins found in patients’ blood may help distinguish between prostate cancer and…
On Oct. 10, 2002, the Oregon Opportunity arrived as Oregon Health & Science University (OHSU) broke ground for…
On Sept. 10, 2002, the Public Health Security and Bioterrorism Preparedness and Response Act (P.L. 107-188) was passed…
In Sept. 2002, the Alberta Innovates Centre for Carbohydrate Science (now Alberta Glycomics Centre), began operation with a…
On Jul. 22, 2002, Amgen announced that the U.S. Food and Drug Administration (FDA) had approved Aranesp (darbepoetin…
On Jul. 17, 2002, A National Cancer Institute funded trial showed that postmenopausal women who used estrogen replacement…
On Jul. 16, 2002, Amgen completed it’s acquisition of Immunex Corporation for $16 billion in stock and net…
On Jul. 2, 2002, the University of California, Davis Comprehensive Cancer Center announced it had received National Cancer…
On Jun. 24, 2002, researchers at the University of Minnesota Stem Cell Institute (SCI) announced they had found…
On Jun. 19, 2002, National Cancer Institute (NCI) scientists used microarray technology to determine the patterns of genes…
On Jun. 12, 2002, President George W. Bush signed the Public Health Security and Bioterrorism Preparedness and Response…
On Jun. 8, 2002, the Salt River Pima-Maricopa Indian Community pledged $5 million to the Translational Genomics Research…
In Jun. 2002, the Translational Genomics Research Institute (TGen), a non-profit 501(c)(3) organization focused on developing earlier diagnostics…
On May 19, 2002, researchers from the National Cancer Institute reported that the molecularly targeted drug bevacizumab slowed…